Aspen Pharmacare Statistics
Share Statistics
Aspen Pharmacare has 444.23M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 444.23M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 38 |
| FTD / Avg. Volume | 3.61% |
Short Selling Information
The latest short interest is 2.44K, so 0% of the outstanding
shares have been sold short.
| Short Interest | 2.44K |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is 22.73 and the forward
PE ratio is 10.15.
Aspen Pharmacare's PEG ratio is
-1.44.
| PE Ratio | 22.73 |
| Forward PE | 10.15 |
| PS Ratio | 2.24 |
| Forward PS | 1.1 |
| PB Ratio | 1.18 |
| P/FCF Ratio | 145.09 |
| PEG Ratio | -1.44 |
Financial Ratio HistoryEnterprise Valuation
Aspen Pharmacare has an Enterprise Value (EV) of 124.23B.
| EV / Sales | 2.78 |
| EV / EBITDA | 12.54 |
| EV / EBIT | 19.96 |
| EV / FCF | 180.04 |
Financial Position
The company has a current ratio of 1.81,
with a Debt / Equity ratio of 0.43.
| Current Ratio | 1.81 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 3.68 |
| Debt / FCF | 52.83 |
| Interest Coverage | 3.14 |
Financial Efficiency
Return on Equity is 5.19% and Return on Invested Capital is 4.28%.
| Return on Equity | 5.19% |
| Return on Assets | 3.16% |
| Return on Invested Capital | 4.28% |
| Revenue Per Employee | $5,041,840.53 |
| Profits Per Employee | $496,673.06 |
| Employee Count | 8,867 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 1.4 |
Taxes
| Income Tax | 1.31B |
| Effective Tax Rate | 22.93% |
Stock Price Statistics
The stock price has increased by -47.62% in the
last 52 weeks. The beta is 0.44, so Aspen Pharmacare's
price volatility has been higher than the market average.
| Beta | 0.44 |
| 52-Week Price Change | -47.62% |
| 50-Day Moving Average | 7.87 |
| 200-Day Moving Average | 9.65 |
| Relative Strength Index (RSI) | 40.74 |
| Average Volume (20 Days) | 1,052 |
Income Statement
In the last 12 months, Aspen Pharmacare had revenue of 44.71B
and earned 4.4B
in profits. Earnings per share was 9.91.
| Revenue | 44.71B |
| Gross Profit | 19.42B |
| Operating Income | 7B |
| Net Income | 4.4B |
| EBITDA | 9.9B |
| EBIT | 7.94B |
| Earnings Per Share (EPS) | 9.91 |
Full Income StatementBalance Sheet
The company has 12.34B in cash and 36.46B in
debt, giving a net cash position of -24.12B.
| Cash & Cash Equivalents | 12.34B |
| Total Debt | 36.46B |
| Net Cash | -24.12B |
| Retained Earnings | 60.76B |
| Total Assets | 139.16B |
| Working Capital | 19.71B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 6.22B
and capital expenditures -5.54B, giving a free cash flow of 690M.
| Operating Cash Flow | 6.22B |
| Capital Expenditures | -5.54B |
| Free Cash Flow | 690M |
| FCF Per Share | 1.55 |
Full Cash Flow StatementMargins
Gross margin is 43.43%, with operating and profit margins of 15.65% and 9.85%.
| Gross Margin | 43.43% |
| Operating Margin | 15.65% |
| Pretax Margin | 12.78% |
| Profit Margin | 9.85% |
| EBITDA Margin | 22.16% |
| EBIT Margin | 15.65% |
| FCF Margin | 1.54% |
